Investor mix
6 investors on record; lead investors include Blue Ledge Capital, Evolution VC Partners, Vice Ventures, Gaingels.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 67% |
| Other / undisclosed | 2 | 33% |
Developer of inhaled drug delivery devices to deliver a broad range of pharmaceuticals
6 investors on record; lead investors include Blue Ledge Capital, Evolution VC Partners, Vice Ventures, Gaingels.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 67% |
| Other / undisclosed | 2 | 33% |